原著 |
|
|
|
|
趋化因子CXCL12可能参与白细胞介素17A对小鼠肺成纤维细胞的活化 |
王华英( ),吕佳佩,陈丽萍,俞万钧*( ) |
宁波大学附属人民医院 宁波市鄞州人民医院呼吸与危重症医学科, 浙江 宁波 315040 |
|
IL-17A activates mouse lung fibroblasts through promoting chemokine CXCL12 secretion |
WANG Huaying( ),LYU Jiapei,CHEN Liping,YU Wanjun*( ) |
Department of Respiratory and Critical Care Medicine, People's Hospital Affiliated to Ningbo University, Yinzhou People's Hospital, Ningbo 315040, Zhejiang Province, China |
引用本文:
王华英,吕佳佩,陈丽萍,俞万钧. 趋化因子CXCL12可能参与白细胞介素17A对小鼠肺成纤维细胞的活化[J]. 浙江大学学报(医学版), 2020, 49(6): 758-764.
WANG Huaying,LYU Jiapei,CHEN Liping,YU Wanjun. IL-17A activates mouse lung fibroblasts through promoting chemokine CXCL12 secretion. J Zhejiang Univ (Med Sci), 2020, 49(6): 758-764.
链接本文:
http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2020.12.11
或
http://www.zjujournals.com/med/CN/Y2020/V49/I6/758
|
1 |
DISTLER J , GY?RFI A H , RAMANUJAM M et al. Shared and distinct mechanisms of fibrosis[J]. Nat Rev Rheumatol, 2019, 15 (12): 705- 730
doi: 10.1038/s41584-019-0322-7
|
2 |
ZHANG J , WANG D , WANG L et al. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease[J]. Am J Physiol Lung Cell Mol Physiol, 2019, 316 (3): L487- L497
doi: 10.1152/ajplung.00301.2018
|
3 |
SHU H K , YOON Y , HONG S et al. Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis[J]. PLoS One, 2013, 8 (11): e79768
doi: 10.1371/journal.pone.0079768
|
4 |
WILLIS B C , DUBOIS R M , BOROK Z . Epithelial origin of myofibroblasts during fibrosis in the lung[J]. Proc Am Thorac Soc, 2006, 3 (4): 377- 382
doi: 10.1513/pats.200601-004TK
|
5 |
BETTELLI E , KORN T , OUKKA M et al. Induction and effector functions of T(H)17 cells[J]. Nature, 2008, 453 (7198): 1051- 1057
doi: 10.1038/nature07036
|
6 |
EVASOVIC J M , SINGER C A . Regulation of IL-17A and implications for TGF-β1 comodulation of airway smooth muscle remodeling in severe asthma[J]. Am J Physiol Lung Cell Mol Physiol, 2019, 316 (5): L843- L868
doi: 10.1152/ajplung.00416.2018
|
7 |
DOS SANTOS T M , RIGHETTI R F , CAMARGO L et al. Effect of anti-IL17 antibody treatment alone and in combination with rho-kinase inhibitor in a murine model of asthma[J]. Front Physiol, 2018, 9:1183
doi: 10.3389/fphys.2018.01183
|
8 |
WANG H , PENG W , WENG Y et al. Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposure[J]. Int Immunopharmacol, 2012, 14 (4): 504- 512
doi: 10.1016/j.intimp.2012.09.011
|
9 |
WANG H , YING H , WANG S et al. Imbalance of peripheral blood Th17 and Treg responses in patients with chronic obstructive pulmonary disease[J]. Clin Respir J, 2015, 9 (3): 330- 341
doi: 10.1111/crj.12147
|
10 |
BONNER J C . Regulation of PDGF and its receptors in fibrotic diseases[J]. Cytokine Growth Factor Rev, 2004, 15 (4): 255- 273
doi: 10.1016/j.cytogfr.2004.03.006
|
11 |
JANSSENS R , STRUYF S , PROOST P . Pathological roles of the homeostatic chemokine CXCL12[J]. Cytokine Growth Factor Rev, 2018, 44:51- 68
doi: 10.1016/j.cytogfr.2018.10.004
|
12 |
DAUBEUF F , HACHET-HAAS M , GIZZI P et al. An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice[J]. J Biol Chem, 2013, 288 (17): 11865- 11876
doi: 10.1074/jbc.M112.449348
|
13 |
GONZALO J A , LLOYD C M , PELED A et al. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease[J]. J Immunol, 2000, 165 (1): 499- 508
doi: 10.4049/jimmunol.165.1.499
|
14 |
MAKINO H , AONO Y , AZUMA M et al. Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice[J]. J Med Invest, 2013, 60 (1-2): 127- 137
doi: 10.2152/jmi.60.127
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|